PortalPublikationenCancer control and functional outcomes of salvage radical pr...

Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature.

Standard

Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. / Chade, Daher C; Eastham, James; Graefen, Markus; Hu, Jim C; Karnes, R Jeffrey; Klotz, Laurence; Montorsi, Francesco; van Poppel, Hendrik; Scardino, Peter T; Shariat, Shahrokh F.

in: EUR UROL, Jahrgang 61, Nr. 5, 5, 2012, S. 961-971.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Chade, DC, Eastham, J, Graefen, M, Hu, JC, Karnes, RJ, Klotz, L, Montorsi, F, van Poppel, H, Scardino, PT & Shariat, SF 2012, 'Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature.', EUR UROL, Jg. 61, Nr. 5, 5, S. 961-971. <http://www.ncbi.nlm.nih.gov/pubmed/22280856?dopt=Citation>

APA

Chade, D. C., Eastham, J., Graefen, M., Hu, J. C., Karnes, R. J., Klotz, L., Montorsi, F., van Poppel, H., Scardino, P. T., & Shariat, S. F. (2012). Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. EUR UROL, 61(5), 961-971. [5]. http://www.ncbi.nlm.nih.gov/pubmed/22280856?dopt=Citation

Vancouver

Chade DC, Eastham J, Graefen M, Hu JC, Karnes RJ, Klotz L et al. Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. EUR UROL. 2012;61(5):961-971. 5.

Bibtex

@article{b988a07a21e14bd2bf9ef5b040aa6d8a,
title = "Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature.",
abstract = "Prostate cancer (PCa) recurrence following definitive radiation therapy (RT) remains a vexing challenge for the practicing physician. Salvage radical prostatectomy (SRP) has not been recognized yet as a valuable therapeutic option.",
keywords = "Humans, Male, Risk Factors, Treatment Outcome, Prognosis, Patient Selection, Neoplasm Grading, Prostate-Specific Antigen/blood, Prostatectomy/*methods, *Salvage Therapy, Adenocarcinoma/diagnosis/epidemiology/radiotherapy/*surgery, Prostatic Neoplasms/diagnosis/epidemiology/radiotherapy/*surgery, Humans, Male, Risk Factors, Treatment Outcome, Prognosis, Patient Selection, Neoplasm Grading, Prostate-Specific Antigen/blood, Prostatectomy/*methods, *Salvage Therapy, Adenocarcinoma/diagnosis/epidemiology/radiotherapy/*surgery, Prostatic Neoplasms/diagnosis/epidemiology/radiotherapy/*surgery",
author = "Chade, {Daher C} and James Eastham and Markus Graefen and Hu, {Jim C} and Karnes, {R Jeffrey} and Laurence Klotz and Francesco Montorsi and {van Poppel}, Hendrik and Scardino, {Peter T} and Shariat, {Shahrokh F}",
year = "2012",
language = "English",
volume = "61",
pages = "961--971",
journal = "EUR UROL",
issn = "0302-2838",
publisher = "Elsevier",
number = "5",

}

RIS

TY - JOUR

T1 - Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature.

AU - Chade, Daher C

AU - Eastham, James

AU - Graefen, Markus

AU - Hu, Jim C

AU - Karnes, R Jeffrey

AU - Klotz, Laurence

AU - Montorsi, Francesco

AU - van Poppel, Hendrik

AU - Scardino, Peter T

AU - Shariat, Shahrokh F

PY - 2012

Y1 - 2012

N2 - Prostate cancer (PCa) recurrence following definitive radiation therapy (RT) remains a vexing challenge for the practicing physician. Salvage radical prostatectomy (SRP) has not been recognized yet as a valuable therapeutic option.

AB - Prostate cancer (PCa) recurrence following definitive radiation therapy (RT) remains a vexing challenge for the practicing physician. Salvage radical prostatectomy (SRP) has not been recognized yet as a valuable therapeutic option.

KW - Humans

KW - Male

KW - Risk Factors

KW - Treatment Outcome

KW - Prognosis

KW - Patient Selection

KW - Neoplasm Grading

KW - Prostate-Specific Antigen/blood

KW - Prostatectomy/methods

KW - Salvage Therapy

KW - Adenocarcinoma/diagnosis/epidemiology/radiotherapy/surgery

KW - Prostatic Neoplasms/diagnosis/epidemiology/radiotherapy/surgery

KW - Humans

KW - Male

KW - Risk Factors

KW - Treatment Outcome

KW - Prognosis

KW - Patient Selection

KW - Neoplasm Grading

KW - Prostate-Specific Antigen/blood

KW - Prostatectomy/methods

KW - Salvage Therapy

KW - Adenocarcinoma/diagnosis/epidemiology/radiotherapy/surgery

KW - Prostatic Neoplasms/diagnosis/epidemiology/radiotherapy/surgery

M3 - SCORING: Journal article

VL - 61

SP - 961

EP - 971

JO - EUR UROL

JF - EUR UROL

SN - 0302-2838

IS - 5

M1 - 5

ER -